Abstract
The identification of the rare but recurrent t(2; 14)(q22; q32) translocation involving the ZEB2 locus in T-cell acute lymphoblastic leukemia, suggested that ZEB2 is an oncogenic driver of this high-risk subtype of leukemia. ZEB2, a zinc finger E-box homeobox binding transcription factor, is a master regulator of cellular plasticity and its expression is correlated with poor overall survival of cancer patients. Recent loss- and gain-of-function in the mouse revealed important roles of ZEB2 during different stages of hematopoiesis, including the T-cell lineage. Here, we summarize the roles of ZEB2 in T-cells, their development, and malignant transformation to T-ALL.
Keywords:
Cancer stem cells; EMT; IL7R; T-cell acute lymphoblastic leukemia; ZEB2.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Cell Transformation, Neoplastic / genetics
-
Cell Transformation, Neoplastic / metabolism*
-
Cell Transformation, Neoplastic / pathology
-
Chromosomes, Human, Pair 14 / genetics
-
Chromosomes, Human, Pair 14 / metabolism
-
Chromosomes, Human, Pair 2 / genetics
-
Chromosomes, Human, Pair 2 / metabolism
-
Humans
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / metabolism*
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
T-Lymphocytes / metabolism*
-
T-Lymphocytes / pathology
-
Translocation, Genetic
-
Zinc Finger E-box Binding Homeobox 2 / genetics
-
Zinc Finger E-box Binding Homeobox 2 / metabolism*
Substances
-
Neoplasm Proteins
-
ZEB2 protein, human
-
Zinc Finger E-box Binding Homeobox 2